Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/9/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Tom Geimer?

Tom Geimer

Partner

Apax

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Apax

Background Information

Employment History

Venture Partner

Heidelberg Innovation


Affiliations

Madeleine Pharmaceuticals Inc

Board Member


U3 Pharma AG

Founder


Cettera Pty Ltd

Founder


Apax Partners LLP

Senior Partner


BioImage A/S

Board Member


Education

Bachelors degree

molecular biology


Honours degree

Molecular Biology


MBA

London Business School


PhD

veterinary science

Hannover , Germany


PhD

veterinary science

University of Wisconsin at Madison


degree

molecular biology

University of Wisconsin at Madison


Web References(24 Total References)


Our Team | Tom Geimer | Madeleine Pharmaceuticals

www.madeleine-pharma.com [cached]

Tom Geimer
Tom Geimer Chief Executive Officer Dr. Geimer co-founded Madeleine and Madeleine Pty. He moved to South Australia in 2008; co-founded Terra Rossa Capital and progressed selected opportunities to companies including Madeleine Pty. With partners at Sage, and co-founders Leigh Berryman and Larry Mahan, Tom assembled the present team. Tom has held positions in various start-ups, corporate management, and on the London stock exchange. Tom contributed to the establishment of venture capital in Europe focused on biotechnology. As a Partner at Apax, he led the successful Genmab investment, a record breaking deal and the spinout Zymogenetics from Novo Nordisk. Tom was a founder of U3 Pharma that sold to Daiichi Sankyo in another record breaking transaction. His expertise in spinouts led to the formation of Madeleine Pty as a spin-out of Hospira (now Pfizer). Tom has a molecular biology (Honors) degree from the University of Wisconsin at Madison and a PhD in veterinary science from Hannover, Germany. He holds a certification in veterinary anesthesiology from Cornell and an MBA from London Business School (Rotary Scholar).


www.madeleine-pharma.com

Tom Geimer
Tom Geimer Chief Executive Officer Dr. Geimer co-founded Madeleine and Madeleine Pty. He moved to South Australia in 2008; co-founded Terra Rossa Capital and progressed selected opportunities to companies including Madeleine Pty. With partners at Sage, and co-founders Leigh Berryman and Larry Mahan, Tom assembled the present team. Tom has held positions in various start-ups, corporate management, and on the London stock exchange. Tom contributed to the establishment of venture capital in Europe focused on biotechnology. As a Partner at Apax, he led the successful Genmab investment, a record breaking deal and the spinout Zymogenetics from Novo Nordisk. Tom was a founder of U3 Pharma that sold to Daiichi Sankyo in another record breaking transaction. His expertise in spinouts led to the formation of Madeleine Pty as a spin-out of Hospira (now Pfizer). Tom has a molecular biology (Honors) degree from the University of Wisconsin at Madison and a PhD in veterinary science from Hannover, Germany. He holds a certification in veterinary anesthesiology from Cornell and an MBA from London Business School (Rotary Scholar).


Tom Geimer | Madeleine Pharmaceuticals

madeleine-pharma.com [cached]

Tom Geimer
Dr. Geimer co-founded Madeleine and Madeleine Pty. He moved to South Australia in 2008; co-founded Terra Rossa Capital and progressed selected opportunities to companies including Madeleine Pty. With partners at Sage, and co-founders Leigh Berryman and Larry Mahan, Tom assembled the present team. Tom has held positions in various start-ups, corporate management, and on the London stock exchange. Tom contributed to the establishment of venture capital in Europe focused on biotechnology. As a Partner at Apax, he led the successful Genmab investment, a record breaking deal and the spinout Zymogenetics from Novo Nordisk. Tom was a founder of U3 Pharma that sold to Daiichi Sankyo in another record breaking transaction. His expertise in spinouts led to the formation of Madeleine Pty as a spin-out of Hospira (now Pfizer). Tom has a molecular biology (Honors) degree from the University of Wisconsin at Madison and a PhD in veterinary science from Hannover, Germany. He holds a certification in veterinary anesthesiology from Cornell and an MBA from London Business School (Rotary Scholar).


Our Team | Madeleine Pharmaceuticals

www.madeleine-pharma.com [cached]

Tom Geimer
Tom Geimer


Madeleine Pharmaceuticals | Cettera

cettera.com [cached]

Madeleine Pharmaceuticals Pty Ltd (Madeleine) was founded in June 2009 by the Entrepreneur in Residence (EIR) for BioInnovation SA (BioSA), namely: Dr. Tom Geimer (Founder).
More on Madeleine by contacting Tom Geimer tom.geimer@madeleine-pharma.com


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory